- Email: [email protected]
State Annual Meetings in Review
• • state annual meetings In review
A
ddresses, panel discussions, house of delegates sessions and the informality of give-and-take between participants on current issues confronting the pharmaceutical profession brought forth resoluti'Ons and goals as various states held their annual pharmaceutical ass'Ociation meetings recently. Federal legislation and programs held the spotlight as pharmacists either endorsed or opposed governmental policies and proposals. Kansas PhaJ1maceutical Association opposed any action where the government is authorized to unilaterally set the price 'Of drugs when it is discriminatory in nature and also called for opposition to a proposed compendium as envisioned by the President. Hugh Cotton, University of Colorado school of pharmacy, speaking before approximately 300 Kansas pharmacists, voiced fears on government price controls on drugs for patients under medicare, Blue Shield/Blue Cross and other third-party payments. Covering the Washington scene for Kansas members was Joseph Oddis, .A!SHP executive secretary. In other government-related action, Minnesota endorsed federal legislation prohibiting mail-order prescription operations and Iowa went on reoord as opposing FDA's proposal to reduce nitroglycerin to nonlegend classHication because of potential misuse and abuse. Montana pharmacists were encouraged to take part in planning f'Or comprehensive health care services and Ohio gave its support to vendor programs in all OEO health centers and asked that OEO officials be encouraged to seek community pharmaceutical counsel in OEO program areas. Speaking in Minnesota, Edward Lawlor Jr. of Smith Kline and French, covered OEO pharmacy development in areas of the country. The professional ·fee, particularly in relationship to third-party payments, came up for debate and discussion in several states. South Dakota Pharmaceutical Association endorsed acceptance of the U.S. government professional fee of $2 for each prescription dispensed whenever such a professional fee is requested by government agencies as a basis for pharmaceutical services reimbursement. Kansas endorsed practice of pharmacists charging for prescription services based on a professional fee commensurate with the professional service provided. Arkansas pharmacists-recognizing that it is becoming increasingly important to know current prescription charges, costs and margins to determine a professional fee for service provided under third-party prescription programs-requested the University of Arkansas to assist in conducting studies to establish two services- ( 1) a continuing cost-finding program to determine the "cost" of dispensing a prescription and (2) a continuing program to determine individual professional fees for pharmaceutical services. Missouri delegates asked that the state weLfare division director allow a substantial increase in the professional fee for dispensing prescriptions under the drug vendor program. With the science of drugs and drug therapy becoming evermore complex, education and continuing educati'On received attention through addresses aI!d committee meetings. Georgia PhaI1maceutical Association resolved to ask its president to appoint a continuing education committee to keep abreast of all developments regarding continuous learning. A panel discussion took place which examined the Georgia pharmacy intern program. California adopted a resolution calling for higher standards for pharmacy student intern training. Iowa called for a study of the possibility of requiring continuing education as a requisite for licensure. Minnesota urged each pharmacist to actively participate in continuing education programs and urged the MSPA pharmaceutical education committee to explore ways in which the association-in cooperation with the University of Minnesota college of pharmacy-can promote and conduct continuing education programs. 456
Journal of the AMERICAN PHARMACEUTICAL ASSOCIATION
Drug abuse themed several meeting sessions as participants sought ways in which to oombat it. In Kansas, the pharmaceutical association resolved that through its public 'ser.vices program, a major emphasis be placed on informing the public of the hazards 'Of drug abuse and misuse and Iowa Pharmaceutical Association scheduled a showing of drug abuse .films. Feeling that the promotion to public of prescription-legend and habitforming drugs is contrary to the best interest .of public welfare, North Carolina urged its legislative committee to arrange for introduction of a bill dUJ1ing 1969 session of General Assembly which would make it illegal directly or indirectly to issue, pub· lish, advertise or promote amounts, prices, fees, premiums, discounts, rebates or credit terms for professional service or for drugs containing narcotics or drugs which may be dispensed only by prescription. Montana also supported enactment of drug abuse controllegislati'On for the state. The professional role 'Of ·t he pharmacist came under scrutiny as North Carolina called for a ,c ommittee to study c.onditions under which pharma:c eutical service is currently being provided in the state, with emphasis on the legal and ethical aspects. In Ohio, the state pharmaceutical association resolved to join with the state board of pharmacy to develop a new updated Ohio Pharmacy Practices Act. In another resolution, Ohio was opposed to any form of licensing or other form of official recognition by the state of any category of personnel other than a pharmacist in dispenSing of dangerous drugs in a licensed pharmacy. At,the Iowa meeting, William L. Blockstein, University of Wisconsin, spoke on family medicati.on records as a pharmacist's responsibility. In the area of prepaid prescription programs, Kansas came out in favor of developing such a program for the state and North Carolina decided to solicit the interest and support of insurance firms, including Blue Cross and Blue Shield in formulating prescription insurance coverage. South Dakota approved a resolution to establish a nonprofit oorporation to handle prepaid prescription insurance. California resolved that under union contracts pharmaceutical services should be provided by :egistered pharmacists only and in Iowa, multiplication of health msurance forms prompted a resolution that a uniform insurance claim be developed. In other meeting highlights-California Pharmaceutical As-
Heading the Arkansas Pharmaceutical Association for the 1968-69 term is Bill D. Plunkett.
Burton D. Magnuson was installed as president of Minnesota State Pharmaceutical Association_
New Arizona Pharmaceutical Association officers are (seated, left to right) William O. Campbell, immediate past president; Mildred Scott, executive secretary; Joseph Nicholls, first vice president; Bruce Beekman, presidentelect; William S. Lackey, president; Otho Hulsey, second vice president; Hy Maza, honorary president; John Campbell, treasurer. Standing (left to right) are executive committee members Wayne Willer, Robert E. Lee, Peter Fumusa, Morton Reich, P.M. Corke, John Carbonaro, John Caldwell, Glen Crandall and Tom Alspach.
sociation, which celebrated its centennial at this year's meeting, asked its directors to negotiate a contract of affiliation with APhA in mutually agreeable terms subject to ratification by the membership. An o-t-c panel on home health-care remedies at the Iowa meeting was taken part in by ,Richard P. Penna, APhA Academy of General Practice secreta,ry, and Paul Lofholm, a community pharmacist. Tangible recognition came in the form of awards by several states presented to pharmacists-some of whom have served for more than 50 years-for their contributions to the profession. After voicing opinions at business sessions, association members adopted the following resolutions~ opposing discriminatory pricing on the part of manufacturers ( Kansas , Arkansas, Missouri, North Carolina, Iowa) .. urging that laws which provide for physicians and nurses to receive commissions upon entering the service be amended to include pharmacists (Georgia, Arkansas) ~ endorsing adoption of metric system (Minnesota, Iowa) I~ stressing freedom of choice of pharmacist for beneficiaries of all third-party payments involving pharmaceutical services, private or governmental (Minnesota) ~ endorsing Hart Bill (S260) (Ohio) ~ opposing Long and ,M ontoya bill either in whole or in part (Minnes'o ta, South Dakota, Missouri) Installation of officers rounded out the meetingsArizona Pharmaceutical Association-William S. Lackey, president; Bruce D. Beekman, president-elect; Joseph Nicholls and Otho Hulsey, vice presidents; John C. Campbell, treasurer; Mildred H. Scott, executive secretary Arkansas Pharmaceutical Association-Bill D. Plunkett, president; Guy Newcomb, president-elect; Joe C. Owen, vice president; Carleton B. Wright, treasurer; William G. Smith, executive secretary California Pharmaceutical Association-A. Basil Harris, president; Edward J. Alstrom, James D. Wagner and Irving Sprugasci, vice presidents; Fred C. Reese, treasurer Florida State Pharmaceutical Association-Wayland White, president; Neil Bitting, president-elect; Joe B. Pace, treasurer; Jeff Keirns, executive secretary Georgia Pharmaceutical Association-W.R. Anderson, president; Henry A. King, president-elect; L.R. Turpen Jr., treasurer Iowa Pharmaceutical Association-Jack Smit, president; Gale Stapp, president-elect; Harold Woodruff and Robert Ohrlund, vice presidents; David Stewart, treasurer; Robert G. Gibbs, executive secretary Kansas Pharmaceutical Association-George White, president; Lewis F. Reid, president-elect; Jake Miller and Kenny Kost, vice
federal control ( continued from page 438)
fully aware of the rapid increase in the number of new drugs being created. In this increase the nation finds both promise and a danger. Some of these new drugs have done much-and promise more-in the cure or control of disease and mental disorders. Others of little or no medical value become the temptation of the alienated-the doom of the unknowing. Under the President's plan which
Newly elected leaders of Iowa Pharmaceutical Association are (left to right) Dave Stewart, treasurer; Bob Ohrlund, second vice president; Jack Smit, president; Harold Woodruff, first vice president; Gale Stapp, president-elect. presidents; George Reeder, treasurer; John L. Rose, executive director Minnesota State Pharmaceutical Association-Burton D. Magnuson, president; Russell F. King and William F. Appel, vice presidents; Russell A. Boogren Jr.; Donald A. Dee, executive secretary Missouri Pharmaceutical Association-E. Frank Foster, president; Sidney B. Smith, president-elect; Mathew W. Wilson and George E. Mallams, vice presidents; Russell Rosenhauer, treasurer; Shelton E. Bower, secretary; Cora D. Cox, executive secretary Montana State Pharmaceutical Association-Ray C. Steiner, president; Duane L. Erickson, president-elect; Joseph Lesar, James G. Schulz and Lloyd L. Callison, vice presidents; Duane L. Erickson, treasurer; Raymond J. Bennett, secretary; Roderic R. Gudgel, executive secretary North Carolina Pharmaceutical Association-James L. Creech, president; Earl H. Tate, B. Cade Brooks and John C. Hood Jr., vice presidents; W. J. Smith, treasurer Ohio State Pharmaceutical Association-Glenn E. Hotaling, president; Dale T. Cochran, president-elect; Jack Karlin, treasurer; John William Mannino, chairman of board of directors Oklahoma Pharmaceutical Association-Carl Bogdahn, president; Maurice Willis, president-elect; Carl Lyons, Walter Scheffe and Keith Gilliam, vice presidents; W. A. Taylor, treasurer; Elbert R. Weaver, executive secretary South Dakota Pharmaceutical Association-Robert Ehrke, president; Clayton Scott, president-elect; James Rogers, George Tibbs and Wiley D. Vogt, vice presidents; Joe Cholik, treasurer; Harold H. Schuler, secretary and executive secretary
created the Bureau of N arcortics and Dangerous Drugs, it is the assignment of the attorney general to designate the new drugs which must be controlled. Experience has shown that in the course of criminal investigations, drugs and combinations of drugs previously unreported will be uncovered. These will be delivered immediately to laboratories and to an advisory committee of scientists who will inform the attorney general on their properties and their capacity for
good or evil. In this relationshipformed by law enforcement's requirement to control what is perilous and to prosecute illegal traffickers in the perilous-we see a new link between the Department of Justice and the great scientific community. This relationship must be ever strengthened to the end that crime control, research and public education together will provide a comprehensive format for dealing with one of our gravest national problems . • Vol. NS8, No.8, August 1968
457
A
ddresses, panel discussions, house of delegates sessions and the informality of give-and-take between participants on current issues confronting the pharmaceutical profession brought forth resoluti'Ons and goals as various states held their annual pharmaceutical ass'Ociation meetings recently. Federal legislation and programs held the spotlight as pharmacists either endorsed or opposed governmental policies and proposals. Kansas PhaJ1maceutical Association opposed any action where the government is authorized to unilaterally set the price 'Of drugs when it is discriminatory in nature and also called for opposition to a proposed compendium as envisioned by the President. Hugh Cotton, University of Colorado school of pharmacy, speaking before approximately 300 Kansas pharmacists, voiced fears on government price controls on drugs for patients under medicare, Blue Shield/Blue Cross and other third-party payments. Covering the Washington scene for Kansas members was Joseph Oddis, .A!SHP executive secretary. In other government-related action, Minnesota endorsed federal legislation prohibiting mail-order prescription operations and Iowa went on reoord as opposing FDA's proposal to reduce nitroglycerin to nonlegend classHication because of potential misuse and abuse. Montana pharmacists were encouraged to take part in planning f'Or comprehensive health care services and Ohio gave its support to vendor programs in all OEO health centers and asked that OEO officials be encouraged to seek community pharmaceutical counsel in OEO program areas. Speaking in Minnesota, Edward Lawlor Jr. of Smith Kline and French, covered OEO pharmacy development in areas of the country. The professional ·fee, particularly in relationship to third-party payments, came up for debate and discussion in several states. South Dakota Pharmaceutical Association endorsed acceptance of the U.S. government professional fee of $2 for each prescription dispensed whenever such a professional fee is requested by government agencies as a basis for pharmaceutical services reimbursement. Kansas endorsed practice of pharmacists charging for prescription services based on a professional fee commensurate with the professional service provided. Arkansas pharmacists-recognizing that it is becoming increasingly important to know current prescription charges, costs and margins to determine a professional fee for service provided under third-party prescription programs-requested the University of Arkansas to assist in conducting studies to establish two services- ( 1) a continuing cost-finding program to determine the "cost" of dispensing a prescription and (2) a continuing program to determine individual professional fees for pharmaceutical services. Missouri delegates asked that the state weLfare division director allow a substantial increase in the professional fee for dispensing prescriptions under the drug vendor program. With the science of drugs and drug therapy becoming evermore complex, education and continuing educati'On received attention through addresses aI!d committee meetings. Georgia PhaI1maceutical Association resolved to ask its president to appoint a continuing education committee to keep abreast of all developments regarding continuous learning. A panel discussion took place which examined the Georgia pharmacy intern program. California adopted a resolution calling for higher standards for pharmacy student intern training. Iowa called for a study of the possibility of requiring continuing education as a requisite for licensure. Minnesota urged each pharmacist to actively participate in continuing education programs and urged the MSPA pharmaceutical education committee to explore ways in which the association-in cooperation with the University of Minnesota college of pharmacy-can promote and conduct continuing education programs. 456
Journal of the AMERICAN PHARMACEUTICAL ASSOCIATION
Drug abuse themed several meeting sessions as participants sought ways in which to oombat it. In Kansas, the pharmaceutical association resolved that through its public 'ser.vices program, a major emphasis be placed on informing the public of the hazards 'Of drug abuse and misuse and Iowa Pharmaceutical Association scheduled a showing of drug abuse .films. Feeling that the promotion to public of prescription-legend and habitforming drugs is contrary to the best interest .of public welfare, North Carolina urged its legislative committee to arrange for introduction of a bill dUJ1ing 1969 session of General Assembly which would make it illegal directly or indirectly to issue, pub· lish, advertise or promote amounts, prices, fees, premiums, discounts, rebates or credit terms for professional service or for drugs containing narcotics or drugs which may be dispensed only by prescription. Montana also supported enactment of drug abuse controllegislati'On for the state. The professional role 'Of ·t he pharmacist came under scrutiny as North Carolina called for a ,c ommittee to study c.onditions under which pharma:c eutical service is currently being provided in the state, with emphasis on the legal and ethical aspects. In Ohio, the state pharmaceutical association resolved to join with the state board of pharmacy to develop a new updated Ohio Pharmacy Practices Act. In another resolution, Ohio was opposed to any form of licensing or other form of official recognition by the state of any category of personnel other than a pharmacist in dispenSing of dangerous drugs in a licensed pharmacy. At,the Iowa meeting, William L. Blockstein, University of Wisconsin, spoke on family medicati.on records as a pharmacist's responsibility. In the area of prepaid prescription programs, Kansas came out in favor of developing such a program for the state and North Carolina decided to solicit the interest and support of insurance firms, including Blue Cross and Blue Shield in formulating prescription insurance coverage. South Dakota approved a resolution to establish a nonprofit oorporation to handle prepaid prescription insurance. California resolved that under union contracts pharmaceutical services should be provided by :egistered pharmacists only and in Iowa, multiplication of health msurance forms prompted a resolution that a uniform insurance claim be developed. In other meeting highlights-California Pharmaceutical As-
Heading the Arkansas Pharmaceutical Association for the 1968-69 term is Bill D. Plunkett.
Burton D. Magnuson was installed as president of Minnesota State Pharmaceutical Association_
New Arizona Pharmaceutical Association officers are (seated, left to right) William O. Campbell, immediate past president; Mildred Scott, executive secretary; Joseph Nicholls, first vice president; Bruce Beekman, presidentelect; William S. Lackey, president; Otho Hulsey, second vice president; Hy Maza, honorary president; John Campbell, treasurer. Standing (left to right) are executive committee members Wayne Willer, Robert E. Lee, Peter Fumusa, Morton Reich, P.M. Corke, John Carbonaro, John Caldwell, Glen Crandall and Tom Alspach.
sociation, which celebrated its centennial at this year's meeting, asked its directors to negotiate a contract of affiliation with APhA in mutually agreeable terms subject to ratification by the membership. An o-t-c panel on home health-care remedies at the Iowa meeting was taken part in by ,Richard P. Penna, APhA Academy of General Practice secreta,ry, and Paul Lofholm, a community pharmacist. Tangible recognition came in the form of awards by several states presented to pharmacists-some of whom have served for more than 50 years-for their contributions to the profession. After voicing opinions at business sessions, association members adopted the following resolutions~ opposing discriminatory pricing on the part of manufacturers ( Kansas , Arkansas, Missouri, North Carolina, Iowa) .. urging that laws which provide for physicians and nurses to receive commissions upon entering the service be amended to include pharmacists (Georgia, Arkansas) ~ endorsing adoption of metric system (Minnesota, Iowa) I~ stressing freedom of choice of pharmacist for beneficiaries of all third-party payments involving pharmaceutical services, private or governmental (Minnesota) ~ endorsing Hart Bill (S260) (Ohio) ~ opposing Long and ,M ontoya bill either in whole or in part (Minnes'o ta, South Dakota, Missouri) Installation of officers rounded out the meetingsArizona Pharmaceutical Association-William S. Lackey, president; Bruce D. Beekman, president-elect; Joseph Nicholls and Otho Hulsey, vice presidents; John C. Campbell, treasurer; Mildred H. Scott, executive secretary Arkansas Pharmaceutical Association-Bill D. Plunkett, president; Guy Newcomb, president-elect; Joe C. Owen, vice president; Carleton B. Wright, treasurer; William G. Smith, executive secretary California Pharmaceutical Association-A. Basil Harris, president; Edward J. Alstrom, James D. Wagner and Irving Sprugasci, vice presidents; Fred C. Reese, treasurer Florida State Pharmaceutical Association-Wayland White, president; Neil Bitting, president-elect; Joe B. Pace, treasurer; Jeff Keirns, executive secretary Georgia Pharmaceutical Association-W.R. Anderson, president; Henry A. King, president-elect; L.R. Turpen Jr., treasurer Iowa Pharmaceutical Association-Jack Smit, president; Gale Stapp, president-elect; Harold Woodruff and Robert Ohrlund, vice presidents; David Stewart, treasurer; Robert G. Gibbs, executive secretary Kansas Pharmaceutical Association-George White, president; Lewis F. Reid, president-elect; Jake Miller and Kenny Kost, vice
federal control ( continued from page 438)
fully aware of the rapid increase in the number of new drugs being created. In this increase the nation finds both promise and a danger. Some of these new drugs have done much-and promise more-in the cure or control of disease and mental disorders. Others of little or no medical value become the temptation of the alienated-the doom of the unknowing. Under the President's plan which
Newly elected leaders of Iowa Pharmaceutical Association are (left to right) Dave Stewart, treasurer; Bob Ohrlund, second vice president; Jack Smit, president; Harold Woodruff, first vice president; Gale Stapp, president-elect. presidents; George Reeder, treasurer; John L. Rose, executive director Minnesota State Pharmaceutical Association-Burton D. Magnuson, president; Russell F. King and William F. Appel, vice presidents; Russell A. Boogren Jr.; Donald A. Dee, executive secretary Missouri Pharmaceutical Association-E. Frank Foster, president; Sidney B. Smith, president-elect; Mathew W. Wilson and George E. Mallams, vice presidents; Russell Rosenhauer, treasurer; Shelton E. Bower, secretary; Cora D. Cox, executive secretary Montana State Pharmaceutical Association-Ray C. Steiner, president; Duane L. Erickson, president-elect; Joseph Lesar, James G. Schulz and Lloyd L. Callison, vice presidents; Duane L. Erickson, treasurer; Raymond J. Bennett, secretary; Roderic R. Gudgel, executive secretary North Carolina Pharmaceutical Association-James L. Creech, president; Earl H. Tate, B. Cade Brooks and John C. Hood Jr., vice presidents; W. J. Smith, treasurer Ohio State Pharmaceutical Association-Glenn E. Hotaling, president; Dale T. Cochran, president-elect; Jack Karlin, treasurer; John William Mannino, chairman of board of directors Oklahoma Pharmaceutical Association-Carl Bogdahn, president; Maurice Willis, president-elect; Carl Lyons, Walter Scheffe and Keith Gilliam, vice presidents; W. A. Taylor, treasurer; Elbert R. Weaver, executive secretary South Dakota Pharmaceutical Association-Robert Ehrke, president; Clayton Scott, president-elect; James Rogers, George Tibbs and Wiley D. Vogt, vice presidents; Joe Cholik, treasurer; Harold H. Schuler, secretary and executive secretary
created the Bureau of N arcortics and Dangerous Drugs, it is the assignment of the attorney general to designate the new drugs which must be controlled. Experience has shown that in the course of criminal investigations, drugs and combinations of drugs previously unreported will be uncovered. These will be delivered immediately to laboratories and to an advisory committee of scientists who will inform the attorney general on their properties and their capacity for
good or evil. In this relationshipformed by law enforcement's requirement to control what is perilous and to prosecute illegal traffickers in the perilous-we see a new link between the Department of Justice and the great scientific community. This relationship must be ever strengthened to the end that crime control, research and public education together will provide a comprehensive format for dealing with one of our gravest national problems . • Vol. NS8, No.8, August 1968
457